Figure 5. Doxycycline dose-dependently inhibits tumor-sphere formation in MCF7 and T47D cells, two commonly used ER(+) breast cancer cell lines.

Doxcycline was initially tested over the range of 1 μM to 250 μM. Note that 50-to-100 μM was the most effective. (*)p <0.001.